Skip to Main Content

Paper Details

Rejection of Aducanumab (Aduhelm) by the Health Care Community: Lessons Learned and the Path Ahead.
Med Care
4
2022
Author NameAffiliation
George Caleb AlexanderCenter for Drug Safety and Effectiveness.
George Caleb AlexanderJohns Hopkins Bloomberg School of Public Health
  • 1 - 2

Datasets

Release 1.2